Cargando…
Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus
Calcineurin inhibitors (CNIs) are effective agents used for prevention of graft-vs-host disease after allogeneic hematopoietic stem cell transplant or for organ rejection in solid-organ transplant. However, CNIs have a wide range of adverse effects that may necessitate changing to another CNI or imm...
Autores principales: | Goklemez, Sencer, Curtis, Lauren M., Hawwa, Alao, Ling, Alexander, Avila, Daniele, Heller, Theo, Pavletic, Steven Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134909/ https://www.ncbi.nlm.nih.gov/pubmed/30225417 http://dx.doi.org/10.1016/j.mayocpiqo.2017.06.004 |
Ejemplares similares
-
Clinical Characterization and Cytokine Profile of Fatigue in Hematologic Malignancy Patients with Chronic Graft-Versus-Host Disease
por: Goklemez, Sencer, et al.
Publicado: (2021) -
Endoscopic Botulinum Toxin Injection for Tacrolimus-Induced Achalasia in a Renal Transplant Recipient
por: Campos, Marilia, et al.
Publicado: (2019) -
Immunotherapy in hematologic malignancies: past, present, and future
por: Im, Annie, et al.
Publicado: (2017) -
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease
por: Zelic Kerep, Ana, et al.
Publicado: (2022) -
Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection
por: Habeeb, Ehsan, et al.
Publicado: (2023)